Polymorphism at the TNF loci in rheumatoid arthritis

Tissue Antigens

Volumn 49, Issue 1, 1997, Pages 74-78

  Vinasco, J ^a   Beraun Y ^a   Nieto, A ^a   Fraile, A ^a   Mataran, L ^b   Pareja, E ^b   Martin, J ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

HLA; Polymorphism; Rheumatoid arthritis; TNF

Indexed keywords

LYMPHOTOXIN; RESTRICTION ENDONUCLEASE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RHEUMATOID ARTHRITIS;

EID: 0031033902     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1997.tb02715.x     Document Type: Article

References (35)

1. Winchester R. The molecular basis of susceptibility to rheumatoid arthritis. Adv Immunol 1994: 56: 389-466.
2. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis - an approach to understanding the molecular genetics of rheumatoid arthritis. Arthritis Rheum 1987: 30: 1205-1213.
3. Wordsworth BP, Bell J. Polygenic susceptibility in rheumatoid arthritis. Ann Rheum Dis 1991: 50: 343-346.
4. McDaniel O, Alarcón GS, Pratt PW, Reveille JD. Most African-American patients with rheumatoid arthritis do not have the rheumatoid antigenic determinant (epitope). Ann Intern Med 1995: 123: 181-187.
5. Spies T, Morton CC, Nedospasov SA, Fiers W, Pious D, Strominger JL. Genes for the tumor necrosis factor α and β are linked to the human major histocompatibility complex. Proc Natl Acad Sci U S A 1986: 83: 8699-8702.
6. Ruddle NH. Tumor necrosis factor (TNF-α) and lymphotoxin (TNF-β). Curr Opin Immunol 1992: 4: 327-332.
7. Breunan FM, Maini RN, Feldman M. TNFα: a pivotal role in rheumatoid arthritis. Br J Rheumatol 1992: 6: 485-516.
8. Keffer J, Probert L, Cazlaris H et al. Transgenic mice expressing human tumour necrosis factor: a predictive model of arthritis. EMBO J 1991: 10: 4025-4031.
9. Elliot MJ, Maini RN, Feldmann M et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α. Arthitis Rheum 1993: 36: 1681-1690.
10. Bendtzen K, Morling N, Fomsgaard, et al. Association between HLA-DR2 and production of tumor necrosis factor alpha and interleukin 1 by mononuclear cells activated by Iipopolysaccharide. Scand J Immunol 1988: 28: 599-606.
11. Jacob CO, Fronek Z, Lewis GD et al. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor-α: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci U S A 1990: 87: 1233-1237.
12. Pociot FJ, Briant CV, Jongeneel J et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-α and TNF-β by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993: 23: 224-231.
13. Wilson AG, di Giovine FS, Blakmore AIF, Duff GW. Single base polymorphism in the human necrosis factor alpha (TNFα) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992: 1: 353.
14. Wilson AG, Gordon C. di Giovine FS et al. A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha. Eur J Immunol 1994: 24: 191-195.
15. Galbraith GMP, Pandey JP. Tumor necrosis factor alpha (TNF-α) gene polymorphism in alopecia areata. Hum Genet 1995: 96: 433-436.
16. McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwiatkowski D. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 1994: 371: 508-511.
17. Cabrera M, Shaw M-A, Sharples C et al. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 1995: 182: 1259-1264.
18. D'Alfonso S, Richiardi PM. A polymorphic variation in a putative regulation box of the TNFα promoter region. Immunogenetics 1994: 39: 150-154.
19. Eiken HG, Odland E, Boman H, Skjerkvale L, Engerbretsen LF, Apold J. Application of natural and amplification-created restriction sites for the diagnosis of PKU mutations. Nucleic Acids Rex 1991: 19: 1427-1430.
20. Messer G, Spengler U. Jung MC et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: an Ncol polymorphism in the first intron of the human TNF-β correlates with a variant amino acid in position 26 and reduces level of TNF-β production. J Exp Med 1991: 173: 209-219.
21. Abraham LJ, French MAH, Dawkins RL. Polymorphic MHC ancestral haplotypes effects the activity of tumor necrosis factor-alpha. Clin Exp Immunol 1993: 92: 14-18
22. Messer G, Spengler U, Jung MC et al. Allelic variation in the TNF-B does not explain the low TNF-B response in patients with primary biliary cirrhosis. Scand J Immunol 1991: 34: 735-740.
23. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988: 31: 315-324.
24. Nieto A, Pareja E. HLA typing by amplification-created restriction sites. Lancet 1992: 340: 735.
25. Fraile A, Vinasco J, Nieto A, Pareja E, Martin J. Typing for TAP alleles using PCR-RFLP with amplification-created restriction sites. Tissue Antigens 1996: 47: 346-352.
26. Yelamos J, Garcia-Lozano Moreno I et al. Association of HLA-DR4-DRw15 (DRB 1*0405) and DR10 with rheumatoid arthritis in a Spanish population. Arthritis Rheum 1993: 36: 811-814.
27. Salvarini C, Macchioni P, Mantovani W et al. Extraarticular manifestation of rheumatoid arthritis and HLA antigen in northern Italy. J Rheumatol 1992: 19: 242-246.
28. Boki KA, Panayi GS, Vaughan RW et al. HLA class II sequence polymorphism and susceptibility to rheumatoid arthritis in Greeks. Arthritis Rheum 1992: 35: 749-755.
29. Olliver W, Thomson W. Population genetics of rheumatoid arthritis. Rheum Dis Clin North Am 1992: 18: 741-759.
30. Davis VA, Millington M, Hyland V, Lawford R, Huand Q, Grennan D. Increase frequency of the uncommon allele of a tumor necrosis factor alpha gene polymorphism in rheumatoid arthritis. Dis Markers 1995: 12: 127-133.
31. Wilson AG, de Vries N, van de Puttie LBA, Duff GW. A tumor necrosis factor apolymorphism is not associated with rheumatoid arthritis. Ann Rheum Dis 1995: 54: 601-603.
32. Pociot F, D'Alfonso S, Compasso S, Scorza R, Richiardi PM. Functional analysis of a new polymorphism in the human TNFα gene promoter. Scand J Immunol 1995: 42: 501-504.
33. Masi AT, Maldonado-Cocco JA, Kaplan SB, Feigenbaum SL, Chandler RW. Prospective study of the early course of rheumatoid arthritis in young adults: comparison of patients with and without rheumatoid factor positively at entry and identification of variables correlating with outcome. Semin Arthritis Rheum 1976: 5: 299-326.
34. Pincus T, Callahan LF. Taking mortality in rheumatoid arthritis seriously - predictive markers, socioeconomic status, and comorbidity. J Rheumatol 1986: 13: 841-845.
35. Weyand CM, Hicok KC, Conn DL, Goronzy JJ. The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med 1992: 117: 801-806.